Qualification: M.Sc. (Microbiology) & Ph.D. (Biophysics)

My background focuses on cancer biology, PARP inhibitors against CSCs, drug resistance in cancer stem cells, biobanking, molecular diagnostics in BRCA mutations, with laboratory skills in assays such as qPCR, flow cytometry, and comet assay. I have written several publications in subjects such as ERK in breast cancer, PARP inhibitors against CSCs, and acridine derivatives as anti-angiogenic agents, while obtaining grants and mentoring groups.

Thrust areas: 

• Cancer Biology and DNA Damage Response (DDR) 
• PARP Inhibitor Resistance in Cancer Stem Cells 
• Tumor Microenvironment and Angiogenesis. 
• Biobanking and Translational Research 
• Molecular Diagnostics 
• Infectious Diseases in Healthcare 

Publications:

• S. Karmakar, R. Dutta and S. Moulik (2025) A transdisciplinary analysis on human papilloma virus and cervical cancer (Review). Discover Medicine (2:35) 1-17. 
• S. Moulik, S. Karmakar, A. Basu, M. Ali and A. Chatterjee (2024) Interdependency and differential expression of ERK1 and ERK2 in breast and melanoma cell lines. JENCI (36) 1-12. 
• Basu*, S. Moulik and S. Karmakar (2023) Bioaccumation of Different Organic Micropollutants in Fishes and its Toxicological and Stress Impacts: A Review. IJRASET (11) 1549-1564 
• S. Moulik, S. Karmakar, A. Basu, S. Mukherjee, Neeraja R and A. Chatterjee (2023) Studies of ERK 1/2 with Respect to Tumor Aggressiveness in B16f10 Murine Melanoma Cells. IJFMR (5) 1- 28 
• AK Madeshiya*, P Banerjee*, S Santra, N Ghosh, S. Karmakar, D Bagchi, S Roy and A Das “Role of metals and metalloids in redox biology” in Metal Toxicology Handbook Ed. D Bagchi., and M Bagchi, CRC Press.2020, 3-12. 
• Banerjee P*, Maitra S*, Bhadra P, Das A, Ghosh N, Karmakar S and Bagchi D. “Nutritional Interventions for the Prevention of Neurodegenerative Disorders” in Antioxidants and Functional Foods for Neurodegenerative Disorders: Uses in Prevention and Therapy Ed. Kumar A and Bagchi D. CRC Press. 2021, 425-435. 
• S. Karmakar* and Siddikuzzaman (2020) Combination Approach of Hyperthermia and Poly (ADPribose) Polymerase (PARP) Inhibitors in Cancer Treatment- A Brief Review. IRJMS 1 (2) 86-93. 
• S. Karmakar and R. Ghosh* (2018) Synergistic action of cispltain and 9-Phenyl acridine in A375 cells. Indian J Biochem Biophys (55) 173-182. 
• S. Karmakar, D. Manna, A. Bagchi, S. Ghosh, S. Hansda, A. Mitra and R. Ghosh* (2017) 9- Phenyl acridine: a possible poly (ADP-ribose) polymerase1 inhibitor. J. Chem. Pharm. Res 9(5) 188-200. 
• S. Karmakar and R. Ghosh* (2015) New Aryl Derivatives of Acridine with Poly (ADP-Ribose) Polymerase 1 Inhibitory Activity: A Molecular Modeling Approach, IJSR 4(12) 1362-1366. ISSN No. 2319-7064. 
• S. Karmakar and R. Ghosh* (2015) A novel inhibitor of Poly (ADP-ribose) polymerase1 (PARP1), J Cancer Sci Ther 7(10) DOI: 10.4172/1948-5956.C1.054, ISSN No.1948-5956. 
• R. Ghosh*, D. Guha, S. Bhowmik and S. Karmakar (2013) Antioxidant enzymes and the mechanism of the bystander effect induced by ultraviolet C irradiation of A375 human melanoma cells. Mut. Res. 757 (2013) 83-90. 
• R. Ghosh*, D. Guha, S. Bhowmik and S. Karmakar (2012) Some UV bystander effects are mediated through induction of antioxidant defense in mammalian cells. Indian J Biochem Biophys 49(5) 371-378.